Home › Lymphoma › New York › Rochester
Lymphoma clinical trials in Rochester, NY
5 studies for Lymphoma are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
RecruitingPhase 3
- Research Site, Rochester
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
RecruitingPhase 3
- University of Rochester, Rochester
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
RecruitingObservational study
- University of Rochester, Rochester
Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
RecruitingPhase 3Healthy volunteers welcome
- Highland Hospital, Rochester
- Pluta Cancer Center, Rochester
- University of Rochester, Rochester
- and 1 more
Umbilical Cord Blood Transplantation From Unrelated Donors
RecruitingObservational study
- Wilmot Cancer Institute, Rochester
About Lymphoma
Lymphoma is a cancer affecting the immune system. Hodgkins Lymphoma and Non Hodgkins Lymphoma are types of lymphoma. Learn about symptoms and treatments.
More about Lymphoma on MedlinePlus
Lymphoma trials in other cities
- Houston, TX34 studies
- New York City, NY33 studies
- Boston, MA33 studies
- Washington, DC23 studies
- Baldwin Park, CA21 studies
- Chicago, IL20 studies
- Durham, NC17 studies
- Philadelphia, PA15 studies
- St. Louis, MO15 studies
- Cleveland, OH13 studies
- Edison, NJ12 studies
- Seattle, WA12 studies
Other studies in Rochester
- Acute Myeloid Leukemia16 studies
- Cancer (all types)15 studies
- Breast Cancer15 studies
- Lung Cancer15 studies
- Obesity14 studies
- Overweight13 studies
- Non-Small Cell Lung Cancer13 studies
- Prostate Cancer10 studies
- Metastatic Cancer8 studies
- Multiple Myeloma8 studies
- Pancreatic Cancer7 studies
- Bladder Cancer7 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.